Vibkacin® Injection (Amikacin Injection IP 500 mg/2 ml) is a broad-spectrum aminoglycoside antibiotic used for the treatment of serious bacterial infections caused by susceptible Gram-negative organisms. It works by inhibiting bacterial protein synthesis, helping to control and eliminate infections effectively. Vibkacin® is indicated for use in respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, skin and soft tissue infections, and other severe bacterial conditions. Manufactured to high-quality standards, Vibkacin® delivers reliable clinical efficacy and is intended for administration through intramuscular (I.M.) or intravenous (I.V.) routes under the supervision of a qualified healthcare professional. For Hospital Use Only.